MedPath

Trifluoperazine

Generic Name
Trifluoperazine
Drug Type
Small Molecule
Chemical Formula
C21H24F3N3S
CAS Number
117-89-5
Unique Ingredient Identifier
214IZI85K3

Overview

A phenothiazine with actions similar to chlorpromazine. It is used as an antipsychotic and an antiemetic.

Indication

For the treatment of anxiety disorders, depressive symptoms secondary to anxiety and agitation.

Associated Conditions

  • Agitation
  • Psychosis
  • Schizophrenia
  • Acute non-psychotic Anxiety

Clinical Trials

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
REMEDYREPACK INC.
70518-2106
ORAL
5 mg in 1 1
2/27/2024
Mylan Pharmaceuticals Inc.
0378-2410
ORAL
10 mg in 1 1
3/31/2015
State of Florida DOH Central Pharmacy
53808-0629
ORAL
2 mg in 1 1
9/30/2013
Mylan Institutional Inc.
51079-572
ORAL
1 mg in 1 1
12/16/2021
Mylan Institutional Inc.
51079-574
ORAL
5 mg in 1 1
12/16/2021
Mylan Pharmaceuticals Inc.
0378-2405
ORAL
5 mg in 1 1
3/31/2015
Mylan Pharmaceuticals Inc.
0378-2401
ORAL
1 mg in 1 1
3/31/2015
Mylan Pharmaceuticals Inc.
0378-2402
ORAL
2 mg in 1 1
3/31/2015
REMEDYREPACK INC.
70518-2095
ORAL
2 mg in 1 1
2/27/2024
State of Florida DOH Central Pharmacy
53808-0819
ORAL
10 mg in 1 1
9/30/2013

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
AA PHARMA TRIFLUOPERAZINE TABLET 5 mg
SIN00289P
TABLET, FILM COATED
5 mg
4/21/1988

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
NOVO-TRIFLUZINE - TAB 5MG
novopharm limited
00021873
Tablet - Oral
5.9 MG
12/31/1971
NOVO-TRIFLUZINE - TAB 10MG
novopharm limited
00021881
Tablet - Oral
11.8 MG
12/31/1971
PMS TRIFLUOPERAZINE TAB 20MG
00726257
Tablet - Oral
20 MG / TAB
12/31/1988
PMS TRIFLUOPERAZINE TAB 1MG
00726214
Tablet - Oral
1 MG / TAB
12/31/1988
NOVO-TRIFLUZINE - TAB 2MG
novopharm limited
00021865
Tablet - Oral
2.36 MG
12/31/1971
NOVO-FLURAZINE TAB 20MG
novopharm limited
00255149
Tablet - Oral
23.6 MG / TAB
12/31/1971
NOVO-FLURAZINE TAB 1MG
novopharm limited
00021857
Tablet - Oral
1.18 MG / TAB
12/31/1971

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.